Aripjanova Shakhlo Sardarovna

 Assistant of the Department

of Clinical Pharmacology TMA

Phone: 150-97-55

E-mail: shakhlo.aripjanova@tma.uz

 Education:

1994-2003 – The First Tashkent State Medical Institute, treatment faculty

2003-2005 – Clinical resident of the Department of Clinical Pharmacology, II Tashkent Medical Institute

2009-2012 – Post-graduate student of the Department of Clinical Pharmacology of the Tashkent Medical Academy (PhD Diploma)

Work experience:

1994-2003 – Student of the Tashkent State Medical Institute

2003-2005 – Clinical resident of the Department of Clinical Pharmacology, II Tashkent Medical Institute

2008-2009 – Assistant of the Department of Clinical Pharmacology, II Tashkent Medical Institute

2009-2012 – Post-graduate student of the Department of Clinical Pharmacology of the Tashkent Medical Academy (PhD Diploma)

2012-2015 – Doctor-therapist of the Republican Center for Reproductive Health of Population

2015- present time –  Assistant of the Department of Clinical Pharmacology of the Tashkent Medical Academy

Scientific activity:

2012 – presentation of the research work: “Features of pharmacodynamics and pharmacodynamic interaction of some hepatoprotectors in the treatment of chronic hepatitis”, Tashkent city

The main areas of practice:

Rational usage of medicines in the treatment of diseases of internal organs.

Scientific activities:

The study of some pathogenetic mechanisms in the development of various pathological conditions and the development of optimal pharmacotherapy schemes.

The main scientific works for the last 5 years:

Articles and theses:

  1. Features of the changes in biliary excretory function of the liver with the use of certain hepatoprotectors and their combinations in the treatment of chronic hepatitis. // International Scientific Review. April 2016, No.4 (14). Boston, USA p. 220-223
  2. The effectiveness of some hepatoprotectors and their combinations on the effect on the content of cytolysis and cholestasis enzymes in the blood of animals with chronic hepatitis. // International Scientific Review. April 2016, No.4 (14). Boston, USA p. 223-227
  3. Clinical use of irbesartan in patients with arterial hypertension in combination with chronic obstructive pulmonary disease. //Scientific research. IX International Scientific and Practical Conference “Scientific Research: Key Problems of the III Millennium”. 2016 No. 8 (9) p.37-41
  4. Recommendations for nutrition in patients with bronchial asthma. Dietology May 2017, p. 24-26
  5. Expert evaluation of the usage of antibiotics in the treatment of community-acquired pneumonia. Scientific and Practical Conference. Therapeutic Bulletin of Uzbekistan. Tashkent 2017. № 3, p.93-94
  6. Evaluation of the effectiveness of the drug “Calcilife D3” for the prevention and treatment of osteoporosis in patients with chronic obstructive pulmonary disease who take inhaled glucocorticosteroids. European Research: Innovation in Science Education and Technology. London, UK 2017 December, p. 85-86

Guides and methodological recommendations:

  1. Modern hepatoprotectors in practical medicine. Guidelines. Tashkent-2011
  2. съезд терапевтов 2017
  3. Соғлом ва пархез овқатланишнинг долзарб мавзулари
  4. scientific-research-8-9
  5. International-scientific-review-4-14 статья 16 год
  6. EUROPEAN RESEARCH 11 (34)-ISSN